HER2-Positive Breast Cancer | Topics

 
Updates From ASCO 2021 for HER2+ Breast Cancer
July 22, 2021

Breast cancer experts review unmet needs in the management of HER2+ metastatic breast cancer and updates from the 2021 ASCO virtual meeting.

Standard of Care for HER2+ Metastatic Breast Cancer
July 22, 2021

Neil Iyengar, MD, leads the discussion on the current standard of care and the sequencing of therapy for HER2+ metastatic breast cancer.

Cynthia Ma, MD, PhD, Discusses Results From a Phase 2 Trial of Neratinib/Fulvestrant in HER2-Mutant Breast Cancer
July 22, 2021

Cynthia Ma, MD, PhD, explains key efficacy findings regarding HER-targeted therapy to treat patients with HER2-mutant breast cancer.